[(177)Lu]Lu-DOTA-ZOL bone pain palliation in patients with skeletal metastases from various cancers: efficacy and safety results

por Yadav, Madhav Prasad, Ballal, Sanjana, Meckel, Marian, Roesch, Frank, Bal, Chandrasekhar
Publicado 2020

(213)Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer

por Sathekge, Mike, Knoesen, Otto, Meckel, Marian, Modiselle, Moshe, Vorster, Mariza, Marx, Sebastian
Publicado 2017

(177)Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatment

por Bergmann, Ralf, Meckel, Marian, Kubíček, Vojtěch, Pietzsch, Jens, Steinbach, Jörg, Hermann, Petr, Rösch, Frank
Publicado 2016

Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases

por Pfannkuchen, Nina, Meckel, Marian, Bergmann, Ralf, Bachmann, Michael, Bal, Chandrasekhar, Sathekge, Mike, Mohnike, Wolfgang, Baum, Richard P., Rösch, Frank
Publicado 2017

Evaluation of Safety and Dosimetry of (177)Lu-DOTA-ZOL for Therapy of Bone Metastases

por Fernández, René, Eppard, Elisabeth, Lehnert, Wencke, Jiménez-Franco, Luis David, Soza-Ried, Cristian, Ceballos, Matías, Ribbeck, Jessica, Kluge, Andreas, Rösch, Frank, Meckel, Marian, Zhernosekov, Konstantin, Kramer, Vasko, Amaral, Horacio
Publicado 2021

Biodistribution and dosimetry of a single dose of albumin-binding ligand [(177)Lu]Lu-PSMA-ALB-56 in patients with mCRPC

por Kramer, Vasko, Fernández, René, Lehnert, Wencke, Jiménez-Franco, Luis David, Soza-Ried, Cristian, Eppard, Elisabeth, Ceballos, Matias, Meckel, Marian, Benešová, Martina, Umbricht, Christoph A., Kluge, Andreas, Schibli, Roger, Zhernosekov, Konstantin, Amaral, Horacio, Müller, Cristina
Publicado 2020